HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 83 filers reported holding HARVARD BIOSCIENCE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $211,000 | +61.1% | 33,916 | +83.2% | 0.00% | – |
| Q4 2021 | $131,000 | -29.2% | 18,516 | -30.0% | 0.00% | – |
| Q3 2021 | $185,000 | -86.3% | 26,465 | -83.7% | 0.00% | -100.0% |
| Q2 2021 | $1,351,000 | +1610.1% | 162,134 | +1019.8% | 0.00% | – |
| Q1 2021 | $79,000 | +16.2% | 14,479 | -8.4% | 0.00% | – |
| Q4 2020 | $68,000 | +23.6% | 15,811 | +23.5% | 0.00% | – |
| Q1 2019 | $55,000 | -11.3% | 12,801 | -21.8% | 0.00% | – |
| Q3 2015 | $62,000 | -68.4% | 16,364 | -65.9% | 0.00% | – |
| Q3 2014 | $196,000 | -10.5% | 47,988 | -0.1% | 0.00% | – |
| Q2 2014 | $219,000 | -4.8% | 48,060 | -1.0% | 0.00% | -100.0% |
| Q1 2014 | $230,000 | -2.5% | 48,549 | -3.5% | 0.00% | 0.0% |
| Q4 2013 | $236,000 | +105.2% | 50,317 | +130.5% | 0.00% | – |
| Q3 2013 | $115,000 | +66.7% | 21,833 | +48.9% | 0.00% | – |
| Q2 2013 | $69,000 | – | 14,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |